3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
6
Completed
3
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Lung Neoplasms
4
Glioblastoma
4
Uterine Cervical Neoplasms
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Brain Neoplasms
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, B-Cell
2
Gliosarcoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Neuroblastoma
1
Neoplasms
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Interventions
Cisplatin
3
X-Rays
2
zimberelimab
1
dl1520
1
Tomography, X-Ray Computed
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiation
1
Practice Guidelines as Topic
1
Polymerase Chain Reaction
1
Platinum
1
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
1
Magnetic Resonance Spectroscopy
1
Gene Expression Profiling
1
Fluorouracil
1
Drug Delivery Systems
1
Carboplatin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Mouth Neoplasms
×
Radiation
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn